Clinical Trials in Texas

Showing 5741-5760 of 15,101 trials

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

NCT02022215

The purpose of the study is to determine the safety and efficacy of high and low strength of ME1111 solutions compared to the vehicle in the treatment of onychomycosis of the toenail.

Onychomycosis

Meiji Seika Pharma Co., Ltd.304 participantsStarted Dec 2013

Birmingham, Alabama, United States • Encinitas, California, United States • San Diego, California, United States +28 more locations

COMPLETEDPhase 355 miles

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

NCT02618434

The purpose of this study is to demonstrate the efficacy, safety, and tolerability of SPN-810 in the treatment of impulsive aggression in patients with Attention-Deficit/Hyperactivity Disorder (ADHD) in conjunction with standard ADHD treatment. Approximately 297 subjects aged 6 to 12 years with ADHD and comorbid impulsive aggression will be recruited in this study. The frequency of impulsive aggression behaviors will be assessed as a primary outcome. Additionally, the severity and improvement in impulsive aggression and quality of life measures for the subject and caregiver will be assessed using validated scales.

Attention Deficit Hyperactivity Disorder (ADHD)

Supernus Pharmaceuticals, Inc.297 participantsStarted Feb 2016

Chandler, Arizona, United States • Little Rock, Arkansas, United States • Imperial, California, United States +29 more locations

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

Find Trials by Condition in Texas

Chronic Plaque Psoriasis (Ps) Registry

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

S-ICD® System Post Approval Study

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Association of Platelet Parameters With Bleeding Severity in Children With ITP

HY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours

Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Mild or Moderate Hepatic Impairment

ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)

Study of the Effect of GM-CSF on Macrophages in Ependymoma

A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer